Activation of NF-κB and COX-2 expression is associated with breakthrough bleeding in patients using oral contraceptives in extended regimens

Gynecological Endocrinology

Volumn 26, Issue 4, 2010, Pages 265-269

  Maia Jr , Hugo ^a   Casoy, Julio ^a   Correia, Tânia ^a   Athayde, Célia ^a   Valente, Jorge ^a   Coutinho, Elsimar M ^a  

^a Centro De Pesquisa E Assistencia Em Reproducao Humana   (Brazil)

Author keywords

Breakthrough bleeding; Cox 2; Extended regimen; Inflammation; NF B

Indexed keywords

CYCLOOXYGENASE 2; ETHINYLESTRADIOL PLUS GESTODENE; GESTINOL; GESTODENE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; UNCLASSIFIED DRUG; ETHINYLESTRADIOL; ORAL CONTRACEPTIVE AGENT; PREGNANE DERIVATIVE;

ADULT; AMENORRHEA; ARTICLE; BREAKTHROUGH BLEEDING; CELL NUCLEUS; DISEASE ASSOCIATION; ENDOMETRIUM; FEMALE; HUMAN; HUMAN TISSUE; HYSTEROSCOPY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MAJOR CLINICAL STUDY; MENORRHAGIA; OBSERVATIONAL STUDY; PATHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UTERUS; CASE CONTROL STUDY; CHEMICALLY INDUCED DISORDER; DRUG ADMINISTRATION; DRUG EFFECT; METABOLISM; METRORRHAGIA; MIDDLE AGED;

ADULT; CASE-CONTROL STUDIES; CONTRACEPTIVES, ORAL, COMBINED; CYCLOOXYGENASE 2; DRUG ADMINISTRATION SCHEDULE; ENDOMETRIUM; ETHINYL ESTRADIOL; FEMALE; HUMANS; INFLAMMATION; MENORRHAGIA; METRORRHAGIA; MIDDLE AGED; NF-KAPPA B; NORPREGNENES;

EID: 77949438284     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590903247832     Document Type: Article

References (20)

1. Rothon Vlasak A, Cheqini N, Hardt N, William RS. Histological characteristics and altered expression of interleukin (IL) IL-13 and IL-15 in endometria of levonorgestrel users with different uterine bleeding patterns. Fertil Steril 2005;83:659-665.
2. Lockwood CJ, Kumar PN, Krikum G, Kadner S, Dubon P, Critchley H, Schatz F. Effects of thrombin, hypoxia and steroids on interleukin-8 expression in decidualized human endometrial stroma cells: implications for long term progestinonly contraceptive induced bleeding. J Clin Endocrinol Metab 2004;89:1467-1475.
3. Lau TM, Witjaksono J, Affandi B, Roqers PA. Expression of progesterone receptor mRNA in the endometrium during the normal menstrual cycle and in Norplant users. Hum Reprod 1996;11:2629-2634.
4. Critchley HO, Kelly RW, Brenner RM, Baird DT. Antiprogestins as a model for progesterone withdrawal. Steroids 2003;68:1061-1068.
5. Horie S, Harada T, Mitsunari M, Taniguchi F, Iwabe T, Terakawa N. Progesterone and progestational compounds attenuate tumor necrosis factor a-induced interleukin-8 production via nuclear factor kB inactivation in endometriotic stromal cells. Fertil Steril 2005;83:1530-1535.
6. Guo SW. Nuclear factor-kB (NF-kB): an unsuspected major culprit in the pathogenesis of endometriosis that is still at large? Gynecol Obstet Invest 2007;63:71-97.
7. Wieser F, Vigne JL, Ryan I, Hornung D, Djalali S, Taylor RN. Sulindac suppresses nuclear factor-kB activation and RANTES gene and protein expression in endometrial stromal cells from women with endometriosis. J Clin Endocrinol Metab 2005;90:6441-6447.
8. Van der Burg V, van der Saag PT. Nuclear factor kB/steroid hormone receptor interaction as functional basis of an antiinflammatory action of steroids in reproductive organs. Mol Hum Reprod 1996;2:433-438.
9. Maia H Jr., Maltez A, Athayde C, Coelho G, Coutinho EM. Insertion of Mirena after endometrial resection in patients with adenomyosis. J Am Assoc Gynecol Laparosc 2003;10: 512-516.
10. Sugino N, Karube-Harada A, Taketani T, Sakata A, Nakamura Y. Withdrawal of ovarian steroids stimulates prostaglandin F2 a production through nuclear factor-kB activation via oxygen radicals in human endometrial stromal cells: potential relevance to menstruation. J Reprod Dev 2004;50:215-225.
11. Jain JK, Li A, Yang W, Minoo P, Felix JC. Mifepristone alters expression of endometrial steroid receptors and their cofactors in new users of medroxyprogesterone acetate. Fertil Steril 2007;87:8-23.
12. Yamauchi N, Harada T, Taniguchi F, Yoshida S, Iwabe T, Terakawa N. Tumor necrosis factor-a induced the release of interleukin-6 from endometriotic stromal cells by the nuclear factor-kB and mitogen-activated protein kinase pathways. Fertil Steril 2004;82 (Suppl 3):1023-1028.
13. Smith OP, Jabbour HN, Critchley HO. Cyclooxygenase enzyme expression and E series prostaglandin receptor signalling are enhanced in heavy menstruation. Hum Reprod 2007;22:1450-1456.
14. Mc Adam BF, Catella, Lawson F, Mardini IA, Kapoor S, Lawson JA, Fitzgerald GA. Systemic biosynthesis of prostacyclin by cyclooxgenase-2; the human pharmacology of a selective inhibitor of Cox-2. Proc Natl Acad Sci USA 1999;96:272-276.
15. Lethaby A, Augood C, Duckitt K, Farquhar C. Nonsteroidal anti-inflammatory drugs for heavy menstrual bleeding. Cochrane Database Syst Rev 2007;(4):CD000400.
16. Nathirojanakun P, Taneepanichskul S, Sappakitkumjorn N. Efficacy of a selective COX-2 inhibitor for controlling irregular uterine bleeding in DMPA users. Contraception 2006;73: 584-587.
17. Maia H, Correia T, Freitas LA, Athayde C, Coutinho E. Cyclooxygenase-2 expression in the endometrium and its relationship to bleeding in users of continuous oral contraceptives. Gynecol Endocrinol 2006;22:96-100.
18. González-Ramos R, Donnez J, Defrère S, Leclercq I, Squifflet J, Lousse JC, Van Langendonckt A. Nuclear factor-kB is constitutively activated in peritoneal endometriosis. Mol Hum Reprod 2007;13:503-509.
19. Schatz F, Krikun G, Caze R, Rahman M, Lockwood CJ. Progestin-regulated expression of tissue factor in decidual cells: implications in endometrial hemostasis, menstruation and angiogenesis. Steroids 2003;68:849-860.
20. Charnock-Jones DS, Macpherson AM, Archer DF, Leslie S, Makkink WK, Sharkey AM, Smith SK. The effect of progestins on vascular endothelial growth factor, oestrogen receptor and progesterone receptor immunoreactivity and endothelial cell density in human endometrium. Hum Reprod 2000;15(Suppl 3):85-95.